| ELIGIBILITY REQUIREMENTS |
| |
· Functional Categories |
| |
|
Research
Health Research - General |
| |
· Applicants |
| |
|
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
Local (Excludes Institutions Of Higher Education And Hospitals)
Public Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Individual/Family
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals) |
| |
· Applicant Eligibility |
| |
|
Research grants, including application for Orphan Product Developments, can be made to any public or private nonprofit university, college, hospital, laboratory or other institution, including State and local units of government. Commercial, nonprofit, and faith-based organizations are also eligible. Small Business Innovation Research (SBIR) grants can only be awarded to domestic small businesses (entities that are independently owned and operated for a profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of the award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the United States and its possessions. |
| |
· Beneficiaries |
| |
|
|
| |
· Beneficiary Eligibility |
| |
|
Colleges, universities, profit-making organizations, nonprofit institutions, hospitals, faith-based and State and local governments. |
| |
· Credentials/Documentation |
| |
|
Research, including Orphan Product Development and conference grant applicants must present a plan and furnish evidence that scientific competence, facilities, and equipment are appropriate to carry out the plan. For Small Business Innovation Research, each applicant must present a research plan and furnish evidence that scientific competence, experimental methods, facilities, equipment, and supplies are appropriate to carry out the plan. Furthermore, in Phase I, there should be an idea or concept with commercial potential, and in Phase II there should be evidence that commercialization of the research results is plausible. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments, for-profit organizations' with Subpart 31.2 of the Federal Acquisition Regulations (FAR), OMB Circular No. A-21 for universities, and OMB Circular No. A-122 for nonprofit organizations. |
See AidPage for more information on:
Food and Drug Administration_Research
See grant announcements for:
Food and Drug Administration_Research
Federal Money Retriever® GrantGate® |
|